Clinical trial
Metronomic Oral Vinorelbine in Patients With Metastatic Tumors
NCT00278070 · Hellenic Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00278070 |
|---|---|
| Title | Metronomic Oral Vinorelbine in Patients With Metastatic Tumors |
| Official title | Metronomic Vinorelbine in Patients With Metastatic Tumors: Phase II Translational Study |
| Lead sponsor | Hellenic Cooperative Oncology Group, Other |
| Collaborators | University of Ioannina |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Non Small Cell Lung Cancer, Prostate Cancer |
| Intervention type | Drug |
| Interventions | vinorelbine oral formulation |
| Start date | Jan 1, 2006 |
| Completion | Feb 1, 2008 |
| First posted | Jan 18, 2006 |
| Last update posted | Feb 29, 2008 |
| Countries | Greece |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: